首页 | 本学科首页   官方微博 | 高级检索  
     

多药耐药相关蛋白1及其与肿瘤关系的研究进展
引用本文:李俊,蒋葵,张学梅. 多药耐药相关蛋白1及其与肿瘤关系的研究进展[J]. 中国临床药理学与治疗学, 2014, 0(3): 351-355
作者姓名:李俊  蒋葵  张学梅
作者单位:[1]大连大学医学院,辽宁大连116622 [2]大连医科大学附属第二医院肿瘤科,辽宁大连116027
基金项目:“十一五”国家科技支撑计划项目(2009BAK61B04)
摘    要:多药耐药(MDR)是导致临床肿瘤化疗失败的重要原因。多药耐药相关蛋白1(MRP1/ABCC1)被认为是介导肿瘤多药耐药的主要跨膜转运蛋白之一。 探究MRP1/ABCC1的结构、功能,以及与肿瘤的关系,有利于指导临床合理用药和肿瘤预后的评估。

关 键 词:多药耐药相关蛋白1  多药耐药  肿瘤

Adervances in the research of multidrug resistance-associated protein 1 and its relationship with tumor
LI Jun,JIANG Kui,ZHANG Xue-mei. Adervances in the research of multidrug resistance-associated protein 1 and its relationship with tumor[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 0(3): 351-355
Authors:LI Jun  JIANG Kui  ZHANG Xue-mei
Affiliation:1 Medical College of Dalian University, Dalian 116622, Liaoning, China ; 2 Department of Oncology, the Second Affiliated Hospital of Dalian Medical University, Dalian 116027, Liaoning ,China)
Abstract:Multidrug resistance(MDR)is a major impediment to the cancer chemotherapy.Multidrug resistance associated protein 1(MRP1/ABCC1)is thought to be one of the main transmembrane proteins that mediate tumor multidrug resistance.Exploring its structure and function,as well as the relationship between MRP1/ABCC1and tumor,will be beneficial to provide an optimal strategy and evaluate the prognosis of tumor.
Keywords:multidrug resistance associated protein 1  multidrug resistance  tumor
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号